|
| View:
Latest News | Top Stories |
|
| Wednesday, Nov 4, 2009 |
|
| · | Synta Pharmaceuticals Reports Third Quarter 2009 Financial Results
Business Wire -
Wed Nov 4 |
|
| · | Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results
Business Wire -
Wed Nov 4 |
|
| Tuesday, Nov 3, 2009 |
|
| · | Myriad Genetics Reports First Quarter Fiscal 2010 Financial Results
GlobeNewswire -
Tue Nov 3 |
|
| · | Biomoda Awarded New Patent
Business Wire -
Tue Nov 3 |
|
| · | Corgenix to Host Conference Call to Discuss Fiscal 2010 First Quarter Results
PR Newswire -
Tue Nov 3 |
|
| · | Breakthrough Results in Depression Care Announced by CNS Response at the U.S. Psychiatric and Mental Health Congress
Marketwire -
Tue Nov 3 |
|
| · | Rosetta Genomics Names Kenneth A. Berlin President and Chief Executive Officer
Business Wire -
Tue Nov 3 |
|
| · | American Heart Association Journal, Circulation, Publishes New Peer-Reviewed Study Involving Protandim(R)
PR Newswire -
Tue Nov 3 |
|
| · | Nasdaq Panel Grants EpiCept's Request for Continued Listing
Business Wire -
Tue Nov 3 |
|
| Monday, Nov 2, 2009 |
|
| · | EpiCept to Present at BIO-Europe 2009
Business Wire -
Mon Nov 2 |
|
| · | SurModics and NuPathe Partner to Develop Novel Long-Acting Parkinson's Treatment
Business Wire -
Mon Nov 2 |
|
| · | OncoGenex Pharmaceuticals to Release Third Quarter 2009 Financial Results
PR Newswire -
Mon Nov 2 |
|
| · | Delaware Chancery Court Allows CNS Response to Continue Financing
Marketwire -
Mon Nov 2 |
|
| · | Infinity Announces Third Quarter 2009 Results Conference Call
GlobeNewswire -
Mon Nov 2 |
|
| Friday, Oct 30, 2009 |
|
| · | Rosetta Genomics to Present at Scientific Conference; Provides Update on Colon Cancer Diagnostic Program
Business Wire -
Fri Oct 30 |
|
| Thursday, Oct 29, 2009 |
|
| · | Orchid Cellmark to Present to the Harvard Investors Group
GlobeNewswire -
Thu Oct 29 |
|
| · | AMAG 3Q loss narrows slightly on anemia drug sales
AP -
Thu Oct 29 |
|
| · | Celldex Therapeutics Presents Positive Clinical Data from Phase 1 Studies of Antibody-Based Cancer Vaccine Candidate, CDX-1307
Business Wire -
Thu Oct 29 |
|
| · | Results of Landmark Depression Efficacy Study to Be Discussed by CNS Response in a Conference Call and Web Conference
Marketwire -
Thu Oct 29 |
|
| · | AMAG Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2009
Business Wire -
Thu Oct 29 |
|
|
More Latest News...
|
